Clinical Trial Update: Imatinib Mesylate and Zoledronic Acid in Patients With Chronic Myeloid Leukaemia in Cytogenetic Response Without Molecular Response [Phase 2]

View source ↗

Summary

Phase 2 trial investigating imatinib mesylate with zoledronic acid in chronic myeloid leukemia patients in cytogenetic response without molecular response; stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• Imatinib mesylate (Imatinib)
• Zoledronic acid (Zoledronic acid)

Snippet

Sponsor: Institut Bergonié | Conditions: Myeloid Leukemia, Chronic | Phase 2 | Status: TERMINATED | Results posted: 2021-10-28